D J Panka - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D J Panka

Showing results (11-20 of 20) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 20 results.

Annals of the New York Academy of Sciences|April 5, 1997

Unique site of autoantibody production in Fas-deficient miceB A Jacobson, L C Foote, D J Panka, et al.

Cellular Immunology|February 1, 1996

Regulation of T-cell death genes: selective inhibition of FasL- but not Fas-mediated functionH Cui, D H Sherr, M el-Khatib, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988

Variable region framework differences result in decreased or increased affinity of variant anti-digoxin antibodiesD J Panka, M Mudgett-Hunter, D R Parks, et al.

Molecular Immunology|August 1, 1993

Defining the structural correlates responsible for loss of arsonate affinity in an IDCR antibody isolated from an autoimmune mouseD J Panka, D L Very, B A Jacobson, et al.

Nature|February 2, 1995

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activationS T Ju, D J Panka, H Cui, et al.

Nature|March 9, 1995

Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cellsT L Rothstein, J K Wang, D J Panka, et al.

The Journal of Biological Chemistry|January 8, 2000

Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growthG D Kamphaus, P C Colorado, D J Panka, et al.

The Journal of Biological Chemistry|March 5, 1991

Altered hapten recognition by two anti-digoxin hybridoma variants due to variable region point mutationsJ F Schildbach, D J Panka, D R Parks, et al.

Protein Science : a Publication of the Protein Society|May 1, 1994

Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibodyJ F Schildbach, S Y Shaw, R E Bruccoleri, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000

Impairment of STAT activation by IL-12 in a patient with atypical mycobacterial and staphylococcal infectionsJ A Gollob, K G Veenstra, H Jyonouchi, et al.

Pageof 2

Search research articles

Showing results (11-20 of 20) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 20 results.

Annals of the New York Academy of Sciences|April 5, 1997

Unique site of autoantibody production in Fas-deficient miceB A Jacobson, L C Foote, D J Panka, et al.

Cellular Immunology|February 1, 1996

Regulation of T-cell death genes: selective inhibition of FasL- but not Fas-mediated functionH Cui, D H Sherr, M el-Khatib, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988

Variable region framework differences result in decreased or increased affinity of variant anti-digoxin antibodiesD J Panka, M Mudgett-Hunter, D R Parks, et al.

Molecular Immunology|August 1, 1993

Defining the structural correlates responsible for loss of arsonate affinity in an IDCR antibody isolated from an autoimmune mouseD J Panka, D L Very, B A Jacobson, et al.

Nature|February 2, 1995

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activationS T Ju, D J Panka, H Cui, et al.

Nature|March 9, 1995

Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cellsT L Rothstein, J K Wang, D J Panka, et al.

The Journal of Biological Chemistry|January 8, 2000

Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growthG D Kamphaus, P C Colorado, D J Panka, et al.

The Journal of Biological Chemistry|March 5, 1991

Altered hapten recognition by two anti-digoxin hybridoma variants due to variable region point mutationsJ F Schildbach, D J Panka, D R Parks, et al.

Protein Science : a Publication of the Protein Society|May 1, 1994

Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibodyJ F Schildbach, S Y Shaw, R E Bruccoleri, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000

Impairment of STAT activation by IL-12 in a patient with atypical mycobacterial and staphylococcal infectionsJ A Gollob, K G Veenstra, H Jyonouchi, et al.

Pageof 2